BIXT OTC
Bioxytran, Inc.
1W: +13.3%
1M: +13.3%
3M: -4.8%
YTD: -66.8%
1Y: -66.3%
3Y: -88.9%
5Y: -88.0%
$0.02
+0.00 (+5.75%)
Weekly Expected Move ±14.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$8K
+4.0% ▲
Operating Income
-$2M
+41.8% ▲
Net Income
-$2M
+44.7% ▲
EPS (Diluted)
$-0.02
+46.4% ▲
EBITDA
-$2M
+41.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $4K | $8K | $8K |
| Gross Profit | $0 | $0 | -$4K | -$8K | -$8K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $545K | $2M | $978K | $1M | $112K |
| SG&A Expenses | $724K | $2M | $1M | $3M | $1M |
| Operating Expenses | $1M | $4M | $2M | $4M | $2M |
| Operating Income | -$1M | -$4M | -$2M | -$4M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $1M | $314K | $520K | $542K | $770K |
| Income Before Tax | -$3M | -$5M | -$3M | -$4M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$4M | -$2M | -$4M | -$2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.04 | $-0.04 | $-0.02 | $-0.03 | $-0.02 |
| EBITDA | $0 | $0 | -$2M | -$4M | -$2M |
| Shares Outstanding | 94M | 106M | 115M | 134M | 139M |